Table II.
Variable | Group 1: PC | Group 2: CS | P value |
---|---|---|---|
Volume/CB unit* | 108.7±37.76 | 112.07±30.56 | NS |
TNCb (×103/μL) | 15.73±3.97 | 13.75±3.63 | 0.01 |
TNCa (×106)/CB unit | 1,742±516 | 1,598±360 | NS |
TNCa (×106)/mL | 21.72±14.6 | 16.98±11.88 | NS |
CD34+ (×106)/CB unit | 4.94±3.3 | 3.96±1.47 | 0.02 |
CD34+ (×106)/mL | 0.06±0.05 | 0.05±0.03 | 0.03 |
Platelets (×103/μL) | 267.45±58 | 254.2±52.61 | NS |
EGF (pg/mL) | 1,386±580 | 1,106±391 | 0.002 |
Haematological parameters of the study population divided according to the two methods of delivery: group 1: PC: physiological childbirth, vaginal delivery; and group 2: CS: Caesarean section; CB: cord blood; TNCb: total nucleated cells before volume reduction; TNCa: total nucleated cells after volume reduction; EGF: epidermal growth factor;
excluding CPD anticoagulant; NS: not significant.